home / stock / abbv / abbv quote
Last: | $173.26 |
---|---|
Change Percent: | 0.55% |
Open: | $173.32 |
Close: | $172.32 |
High: | $174.7299 |
Low: | $172 |
Volume: | 1,634,736 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$173.26 | $173.32 | $172.32 | $174.7299 | $172 | 1,634,736 | 07-22-2024 |
$172.32 | $173.67 | $172.32 | $173.845 | $171.22 | 4,285,894 | 07-19-2024 |
$171.14 | $174.445 | $171.14 | $176.68 | $170.72 | 5,957,924 | 07-18-2024 |
$175.27 | $169.51 | $175.27 | $175.74 | $169.51 | 6,983,160 | 07-17-2024 |
$169.2 | $168.6 | $169.2 | $169.85 | $167.26 | 3,829,646 | 07-16-2024 |
$168.03 | $168.91 | $168.03 | $170.365 | $167.42 | 2,395,181 | 07-15-2024 |
$168.73 | $169.0768 | $168.73 | $170.0628 | $168.3535 | 4,133,520 | 07-12-2024 |
$169.91 | $167.52 | $169.91 | $170.35 | $167.35 | 3,689,530 | 07-11-2024 |
$168.14 | $167.45 | $168.14 | $168.45 | $166.1101 | 3,887,959 | 07-10-2024 |
$168.05 | $167.02 | $168.05 | $168.53 | $164.86 | 4,224,705 | 07-09-2024 |
$166.52 | $166.54 | $166.52 | $167.717 | $165.62 | 3,500,155 | 07-08-2024 |
$167.25 | $164.72 | $167.25 | $167.31 | $163.63 | 5,978,524 | 07-05-2024 |
$163.84 | $166.09 | $163.84 | $167.1 | $163.52 | 3,527,612 | 07-04-2024 |
$163.84 | $166.09 | $163.84 | $167.1 | $163.52 | 3,527,612 | 07-03-2024 |
$165.96 | $168.63 | $165.96 | $168.63 | $165.45 | 5,965,457 | 07-02-2024 |
$170.37 | $171.27 | $170.37 | $173.88 | $169.535 | 5,194,744 | 07-01-2024 |
$171.52 | $169.99 | $171.52 | $171.82 | $169.05 | 24,463,599 | 06-28-2024 |
$168.99 | $171.29 | $168.99 | $171.555 | $167.75 | 5,381,953 | 06-27-2024 |
$171.15 | $170.29 | $171.15 | $172.35 | $170.15 | 5,576,094 | 06-26-2024 |
$170.75 | $172.1 | $170.75 | $173.41 | $170.62 | 5,712,698 | 06-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
2024-07-17 08:25:00 ET Stocks that are trading at low- and discounted-earnings multiples can sometimes be value traps. But other times, it's just due to short-term and temporary factors that the stocks aren't doing terribly well. In these situations, there are opportunities for investors to...
2024-07-14 04:27:00 ET The broader stock market benchmarks keep reaching new heights, but the S&P 500 index's ongoing bull run has been driven heavily by its largest components. That means there are still plenty of reliable dividend-paying stocks that look like bargains. Shares ...
AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ®) in Giant Cell Arteritis PR Newswire Submissions are supported by the Phase 3 SELECT-GCA study demonstrating upadacitinib 15 mg with a 26-week steroid taper regimen achieved the primary endp...